Clinical trial

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

NCT06586515

Study summary

ClinicalTrials.gov

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

8 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention LY3962673 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Cetuximab Normalized identity: cetuximab View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Gemcitabine Normalized identity: gemcitabine View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention nab-paclitaxel Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Oxaliplatin Normalized identity: oxaliplatin View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record leucovorin Normalized identity: leucovorin View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Irinotecan Normalized identity: irinotecan View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention 5-fluorouracil Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-09-12

PhasePHASE1

Conditions

Pancreatic Ductal Adenocarcinomaverified · MONDO: pancreatic ductal adenocarcinoma

Non-small Cell Lung Cancerverified · MONDO: non-small cell lung carcinoma

Colorectal Cancerverified · MONDO: colorectal cancer

Interventions

LY3962673DRUG

CetuximabDRUG · verified · RxNorm: cetuximab

GemcitabineDRUG · verified · RxNorm: gemcitabine

nab-paclitaxelDRUG

OxaliplatinDRUG · verified · RxNorm: oxaliplatin

leucovorinDRUG · verified · RxNorm: leucovorin

IrinotecanDRUG · verified · RxNorm: irinotecan

5-fluorouracilDRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

NashvilleTennessee, United States3 New YorkNew York, United States2 BostonMassachusetts, United States2 MadridSpain2 BarcelonaSpain2 BeijingChina2 HoustonTexas, United States1 AtlantaGeorgia, United States1 San AntonioTexas, United States1 SeattleWashington, United States1 ClevelandOhio, United States1 PittsburghPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06586515 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.